CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-09 | Levitz Michael L EVP, CFO, Treasurer | Shares withheld for taxes | −1,303 | $26.91 | $35K | 23,559 |
| 2023-03-09 | Levitz Michael L EVP, CFO, Treasurer | Grant or award · Restricted Stock Unit | +17,624 | 17,624 | ||
| 2023-03-09 | Levitz Michael L EVP, CFO, Treasurer | Grant or award · Stock Option (Right to Buy) | +38,475 | 38,475 | ||
| 2023-03-09 | Levitz Michael L EVP, CFO, Treasurer | Option exercise · Restricted Stock Unit | −4,439 | 4,438 | ||
| 2023-03-09 | Colleran David EVP, General Counsel, Corp Sec | Option exercise | +3,683 | 15,956 | ||
| 2023-03-09 | Colleran David EVP, General Counsel, Corp Sec | Shares withheld for taxes | −1,081 | $26.91 | $29K | 14,875 |
| 2023-03-09 | Colleran David EVP, General Counsel, Corp Sec | Grant or award · Restricted Stock Unit | +16,395 | 16,395 | ||
| 2023-03-09 | Colleran David EVP, General Counsel, Corp Sec | Grant or award · Stock Option (Right to Buy) | +35,790 | 35,790 | ||
| 2023-03-09 | Colleran David EVP, General Counsel, Corp Sec | Option exercise · Restricted Stock Unit | −3,683 | 3,682 | ||
| 2023-03-09 | Blanchard Cheryl R President, CEO, Director | Option exercise | +14,419 | 87,963 | ||
| 2023-03-09 | Blanchard Cheryl R President, CEO, Director | Shares withheld for taxes | −4,232 | $26.91 | $114K | 83,731 |
| 2023-03-09 | Blanchard Cheryl R President, CEO, Director | Grant or award · Restricted Stock Unit | +60,004 | 60,004 | ||
| 2023-03-09 | Blanchard Cheryl R President, CEO, Director | Grant or award · Stock Option (Right to Buy) | +130,998 | 130,998 | ||
| 2023-03-09 | Blanchard Cheryl R President, CEO, Director | Option exercise · Restricted Stock Unit | −14,419 | 14,420 | ||
| 2023-03-04 | Colleran David EVP, General Counsel, Corp Sec | Option exercise | +2,500 | 13,007 | ||
| 2023-03-04 | Colleran David EVP, General Counsel, Corp Sec | Shares withheld for taxes | −734 | $31.59 | $23K | 12,273 |
| 2023-03-04 | Colleran David EVP, General Counsel, Corp Sec | Option exercise · Restricted Stock Unit | −2,500 | 0 | ||
| 2022-08-10 | Levitz Michael L EVP, CFO, Treasurer | Option exercise | +3,859 | 20,423 | ||
| 2022-08-10 | Levitz Michael L EVP, CFO, Treasurer | Option exercise · Restricted Stock Unit | −3,859 | 3,859 | ||
| 2022-06-08 | VOGT SUSAN L N Director | Grant or award | +7,954 | 23,778 |
Page 10 of 29 · 580 trades